Blastic Plasmacytoid Dendritic Cell Neoplasm: Underlining the importance of an early diagnosis and the use of tagraxofusp therapy before wide dissemination

Australas J Dermatol. 2021 May;62(2):e316-e318. doi: 10.1111/ajd.13399. Epub 2020 Aug 5.

Authors

Cesare Massone¹, Anna Maria Raiola², Alida Dominietto², Paola Minetto², Sabrina Beltramini³, Lorenzo Cerroni⁴, Simona Sola⁵, Emanuele Angelucci²

Affiliations

¹ Dermatology Unit, Galliera Hospital, Genoa, Italy.
² UO Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
³ UO Farmacia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁴ Research Unit Dermatopathology, Department of Dermatology, Medical University of Graz, Graz, Austria.
⁵ Surgical Pathology, Galliera Hospital, Genoa, Italy.

PMID: 32757292
DOI: 10.1111/ajd.13399

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Dendritic Cells / pathology*
Early Detection of Cancer*
Hematologic Neoplasms / drug therapy*
Humans
Male
Recombinant Fusion Proteins / administration & dosage*
Skin Neoplasms / drug therapy*

Substances

Recombinant Fusion Proteins
tagraxofusp